Vysov
Vysov is an oral antidiabetic drug containing Vildagliptin. It belongs to a class of medicines called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the release of insulin from the pancreas and decreasing the production of glucagon, thereby helping to lower blood glucose levels in patients with type 2 diabetes.
Dosage by Body Weight
The usual adult dose is 50 mg once or twice daily, depending on the patient's condition and tolerability. It can be taken with or without food. Dosage must be determined by a healthcare professional.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vildagliptin in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vildagliptin in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vildagliptin in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vildagliptin in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy of Vildagliptin in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy of Vildagliptin in pediatric patients have not been established. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy of Vildagliptin in pediatric patients have not been established. |
| 8-10 kg | Not recommended | Do not use | Safety and efficacy of Vildagliptin in pediatric patients have not been established. |
| 11-15 kg | Not recommended | Do not use | Safety and efficacy of Vildagliptin in pediatric patients have not been established. |
| 16-20 kg | Not recommended | Do not use | Safety and efficacy of Vildagliptin in pediatric patients have not been established. |
Formulation
Tablet
Purpose
Treatment of Type 2 Diabetes Mellitus to improve blood sugar control in adults.
Generic Name
VildagliptinScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.